CNS Metastasis Meeting

Event Notes:

Brain metastases represent one of the most pressing challenges in contemporary oncology. Once considered a late and largely untreatable complication of systemic cancer, they are now recognized as a biologically distinct and increasingly actionable disease. Rapid advances across multiple disciplines—from cancer biology and neuroscience to immunology and clinical research—are reshaping our understanding and opening new therapeutic opportunities. At the same time, these developments demand closer integration between preclinical discovery, translational research, and clinical practice.

This meeting has evolved from the highly successful Brain Mets meeting held since 2011 and marks a new phase in the evolution of the CNS Metastasis Conference. With the joint leadership of EANO and EORTC, our aim is to establish a truly international, multidisciplinary forum that brings together leading experts across the full spectrum of the field. The program has been carefully designed to reflect this ambition, highlighting cutting-edge science alongside clinical innovation, and fostering dialogue between laboratory researchers, clinicians, and trialists.